Sarbajit Mukherjee, MD, MS, Assistant Professor, Gastrointestinal Medical Oncologist at Roswell Park Cancer Institute. In this video, he speaks about the AACR 2022 Abstract – CT105 / 2 – Initial results of a phase II study evaluating a chemokine-modulatory (CKM) regimen in patients with colorectal cancer metastatic to the liver.   Abstract   Origins:   … Continue reading Podcast Sarbajit Mukherjee, MD @Sarbaji85064063 @RoswellPark #AACR22 #ColorectalCancer Phase II Study Evaluating CKM Regimen